As a predictor of post-merger price competition, “willingness to pay” is a potentially powerful tool that federal antitrust agencies are increasingly relying on when assessing proposed hospital mergers. The agencies’ increasing reliance on the technique means that a thorough understanding of it is essential for attorneys involved in hospital merger transactions.
EDM: Merger specificity or alternative reality
In this article published in the December 2021 issue of the ABA Antitrust Magazine Online, Gopal Das Varma addresses two questions related to the pricing...